ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia (2022)
- Authors:
- USP affiliated authors: LACCHINI, FERNANDA BORCHERS COELI - FMRP ; LACCHINI, RICCARDO - EERP ; CAVALLI, RICARDO DE CARVALHO - FMRP ; SANDRIM, VALÉRIA CRISTINA - FMRP
- Unidades: FMRP; EERP
- DOI: 10.2217/pgs-2022-0079
- Subjects: POLIMORFISMO; HIPERTENSÃO; ÓXIDO NÍTRICO; NITRITOS; FARMACOGENÉTICA; PRÉ-ECLÂMPSIA
- Keywords: ARG2; Arginase 2; Genetic polymorphisms; Hypertension; Nitric oxide; Nitrite; Pharmacogenetics; Preeclampsia
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmacogenomics
- ISSN: 1462-2416
- Volume/Número/Paginação/Ano: v. 23, n. 13, p. 713-722, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
LUIZON, Marcelo Rizzatti et al. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 23, n. 13, p. 713-722, 2022Tradução . . Disponível em: https://doi.org/10.2217/pgs-2022-0079. Acesso em: 28 dez. 2025. -
APA
Luizon, M. R., Pinto-Souza, C. C., Coeli-Lacchini, F. B., Lacchini, R., Cavalli, R. de C., & Sandrim, V. C. (2022). ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 23( 13), 713-722. doi:10.2217/pgs-2022-0079 -
NLM
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2025 dez. 28 ] Available from: https://doi.org/10.2217/pgs-2022-0079 -
Vancouver
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2025 dez. 28 ] Available from: https://doi.org/10.2217/pgs-2022-0079 - Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia
- Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia
- Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women
- SIRT1-dependent effects of resveratrol and grape juice in an in vitro model of preeclampsia
- Resveratrol and grape juice: effects on redox status and nitric oxide production of endothelial cells in in vitro preeclampsia model
- Preeclampsia and gestational hypertension: biochemical and antioxidant features in vitro might help understand different outcomes
- Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia
- Circulating levels of tissue inhibitor of metalloproteinase 3, a protein with inhibitory effects on angiogenesis, are increased in pre‐eclampsia
- Markers of endothelial dysfunction are attenuated by resveratrol in preeclampsia
- NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia
Informações sobre o DOI: 10.2217/pgs-2022-0079 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003136816.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
